LOADING
Comparing Microsoft Corporation (MSFT) and Merck & Company (MRK) across the Technology and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | MSFT | MRK |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $2.86T | $305.1B |
| P/E Ratio | 22.9 | 34.8 |
| Forward P/E | 19.8 | 24.4 |
| PEG Ratio | 1.19 | 6.10 |
| EPS | $16.79 | $3.55 |
| Revenue Growth (YoY) | 18.3% | 4.9% |
| Profit Margin | 39.3% | 13.6% |
| Return on Equity | 34.0% | 18.9% |
| Dividend Yield | 0.93% | 2.62% |
| Beta | 1.13 | 0.20 |
| 52-Week High | $551.05 | $130.29 |
| 52-Week Low | $349.20 | $74.18 |
| Volume | -- | -- |
Microsoft Corporation is the larger company by market capitalization. Microsoft Corporation trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Merck & Company offers a higher dividend yield for income investors. Microsoft Corporation has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.